Results 151 to 160 of about 34,750 (223)

Developing Antiviral Vaccines Based on Attenuated <i>Salmonella</i>. [PDF]

Pathogens
Ou E, Liu F.
europepmc   +1 more source

Enhancing HIV-1-specific CAR-T cell functional activity by treatment with a novel cytokine-based scaffold with IL-15 superagonist and TGF-β-neutralizing activity. [PDF]

J Virol
Lamcaj S, Cole E, Hiner C, Santos Bravo M, Zheng JH, Shrestha N, Sowd G, Xiong Y, Zhu Z, Dropulic B, Wong HC, Goldstein H.   +11 more
europepmc   +1 more source

HIV superinfection reveals sequential reservoir reactivation and immune-driven rebound dynamics. [PDF]

J Virol
Omondi FH, Shahid A, Kinloch NN, Dong W, Duncan MC, Yaseen F, Barad E, Moran-Garcia N, Cabral da Silva A, Mysak V, Kirkby D, Ostrowski M, Lynch RM, Brumme CJ, Kovacs C, Jones RB, Lee GQ, Brumme ZL.   +17 more
europepmc   +1 more source

Distinct amino acid signatures and neutralization sensitivity of plasma- and CSF-derived HIV-1 subtype C clones. [PDF]

Retrovirology
Mtanjana S, Gumede N, Zikhali N, Ntshangase N, Sirksson S, Sojane K, Ndung'u T, Ndlovu B.   +7 more
europepmc   +1 more source

Arming Inactivated Enveloped Virus Vaccines with the <i>GGTA1</i> Gene: A Potent Method for Amplification of Viral Vaccines Effectiveness and Protection Against Variants. [PDF]

Vaccines (Basel)
Galili U.
europepmc   +1 more source

HIV-1 BG505 SOSIP immunization induced B cell expansion targeting the 465-glycan hole, with neutralizing antibodies exhibiting distinct binding modes and mechanisms of virus inhibition. [PDF]

PLoS Pathog
Myers A, Chandravanshi M, Whitmore LS, Kohrn BF, Negash A, Nguyen DN, Ralli-Jain P, Cruickshank K, Upadhyay AA, Charles T, Edwards CT, Hunter E, Amara RR, Korzeniowski MK, Niu L, Pozharski E, Tolbert WD, Bosinger SE, Kennedy SR, Pazgier M, Derdeyn CA.   +20 more
europepmc   +1 more source

Illuminating ongoing pain in mice with novel bioluminescent imaging. [PDF]

J Pain
Yuan S, Liew JY, Pal A, Wang J, Zhou Y, Green DP, Motamedi M, Tang SJ.   +7 more
europepmc   +1 more source

A French National Real-World Survey of People With Multiresistant HIV-1 Viruses Receiving an Antiretroviral Regimen Including Fostemsavir or Ibalizumab. [PDF]

Open Forum Infect Dis
Stefic K, Tumiotto C, de Monte A, Wirden M, Rodallec A, Fofana D, Chaix ML, Bellecave P, Garnier E, Sourice J, Vellas C, Raymond S, Lambert-Niclot S, Alidjinou EK, Coulon P, Avettand-Fenoel V, Mchantaf G, Handala L, Alessandri-Gradt E, Moisan A, Lê M, Delaugerre C, Marcelin AG, Peytavin G, Calvez V, Descamps D, Charpentier C, Entry Inhibitors Observatory Study Group, Entry Inhibitors Observatory Study Group .   +28 more
europepmc   +1 more source

Galectin-8 binds HIV envelope glycoproteins with high affinity and promotes viral infectivity. [PDF]

Front Cell Infect Microbiol
Sheik-Khalil E, Kahl-Knutson B, Johansson E, Karlson S, Nilsson UJ, Leffler H, Jansson M.   +6 more
europepmc   +1 more source

Genetic divergence between reservoir and pre-therapy plasma HIV-1 Env variants does not confer consistent compartment-specific differences in broadly neutralizing antibody sensitivity. [PDF]

J Virol
Dlamini S, Ojwach D, Giandhari J, Ndlovu B, Ndhlovu Z, Ndung'u T, Mann J.   +6 more
europepmc   +1 more source